Work

Phase II trial of belantamab mafodotin, carfilzomib, pomalidomide, and dexamethasone in multiple myeloma following BCMA CAR T-cell therapy

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-5832

Authors: Benjamin Derman, Jennifer Cooperrider, Frank Wen, Anna Pula, Ken Jiang, Theodore Karrison, Andrzej Jakubowiak

Institution: University of Chicago

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417002344

Cites:

Cited by:

Related to: